0001567619-23-006844.txt : 20230809 0001567619-23-006844.hdr.sgml : 20230809 20230809124806 ACCESSION NUMBER: 0001567619-23-006844 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230809 DATE AS OF CHANGE: 20230809 EFFECTIVENESS DATE: 20230809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Azora Therapeutics, Inc. CENTRAL INDEX KEY: 0001866534 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-489214 FILM NUMBER: 231154309 BUSINESS ADDRESS: STREET 1: 4267 VALLEY MEADOW ROAD CITY: ENCINO STATE: CA ZIP: 91436 BUSINESS PHONE: .(510) 409-5791 MAIL ADDRESS: STREET 1: 4267 VALLEY MEADOW ROAD CITY: ENCINO STATE: CA ZIP: 91436 D 1 primary_doc.xml X0708 D LIVE 0001866534 Azora Therapeutics, Inc. 4267 Valley Meadow Road Encino CA CALIFORNIA 91436 (818) 276-6726 DELAWARE None None Corporation true Matthew Davidson 4267 Valley Meadow Road Encino CA CALIFORNIA 91436 Executive Officer Director President, Chief Executive Officer, and Chief Financial Officer of the Issuer Julie Saiki 4267 Valley Meadow Road Encino CA CALIFORNIA 91436 Executive Officer Director Secretary of the Issuer Dennis Brown 4267 Valley Meadow Road Encino CA CALIFORNIA 91436 Director Pharmaceuticals Decline to Disclose 06b false 2023-08-02 false true false 0 596426 581449 14977 false 11 0 0 0 false Azora Therapeutics, Inc. /s/ Matthew Davidson Matthew Davidson President, CEO, and CFO 2023-08-08